Showing results (81-90 of 129) with videos related to
Sort By:
Pageof 13
Blood|January 6, 2016
Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitorsPreetesh Jain, Hagop Kantarjian, Keyur P Patel, et al.Cancer|July 28, 2016
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomesTapan M Kadia, Preetesh Jain, Farhad Ravandi, et al.Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.American Journal of Clinical Pathology|February 26, 2011
Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remissionJianlan Sun, C Cameron Yin, Wei Cui, et al.British Journal of Haematology|April 7, 2017
Characteristics, management, and outcomes of patients with follicular dendritic cell sarcomaPreetesh Jain, Sarah A Milgrom, Keyur P Patel, et al.Advances in Radiation Oncology|July 14, 2023
Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of LymphomaSusan Y Wu, Penny Q Fang, Ethan B Wang, et al.Molecular Cancer|September 26, 2022
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphomaVivian Changying Jiang, Dapeng Hao, Preetesh Jain, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 11, 2021
EZH2 expression is associated with inferior overall survival in mantle cell lymphomaDiana Martinez-Baquero, Ali Sakhdari, Huan Mo, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 30, 2010
De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classificationJianlan Sun, Sergej N Konoplev, Xuemei Wang, et al.American Journal of Clinical Pathology|January 21, 2012
CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T/myeloid acute leukemiaDaniela Hoehn, L Jeffrey Medeiros, Su S Chen, et al.Pageof 13